arrow
C

Christine M. Parseghian

md anderson cancer center
H指数:20
被引数:1,599

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Patterns of progression and survival in patients with mismatch repair deficient/ microsatellite instability- high metastatic colorectal cancer treated with immunotherapy

错配修复缺陷/微卫星高度不稳定转移性结直肠癌患者接受免疫治疗后的进展模式和生存情况

2026-07-200
OAAI
Hepatectomy Plus Chemotherapy or Chemotherapy Alone for Resectable Liver and Unresectable Lung Metastases from Colorectal Adenocarcinoma (LUNA): A Randomized Phase II Trial

结直肠癌腺癌可切除肝脏与不可切除肺部转移灶的肝切除术联合化疗或单纯化疗治疗(LUNA):一项随机Ⅱ期临床试验

2025-12-100
PRE
Phase 1/2 trial of encorafenib, cetuximab, and nivolumab in microsatellite stable BRAFV600E metastatic colorectal cancer

Ⅰ/Ⅱ期临床试验:encorafenib、cetuximab和nivolumab在微卫星稳定型BRAFV600E转移性结直肠癌中的应用

2025-08-280
OAAI
A pilot study to assess the safety, tolerability, and tumor responses with lenvatinib plus pembrolizumab in patients with advanced pancreatic ductal adenocarcinoma in second-line or later of
2024-09-150
PRE
A phase I/II trial of a CXCR1/2 inhibitor in combination with anti-PD-1 for circulating tumor DNA (ctDNA) positive & refractoryRAS-mutated microsatellite stable (MSS) colorectal cancer
2023-04-140
PRE
Survival improvement for patients with metastatic colorectal cancer over twenty years
2023-02-1359
OAAI
Phase II study of durvalumab anti-PD-L1) and trametinib (MEKi) in microsatellite stable (MSS) metastatic colorectal cancer (mCRC)
2022-08-2527
OAAI
Prospective Study of Perioperative Circulating Tumor DNA Dynamics in Patients Undergoing Hepatectomy for Colorectal Liver Metastases
2022-07-0626
PRE
KRAS amplification in metastatic colon cancer is associated with a history of inflammatory bowel disease and may confer resistance to anti-EGFR therapy
2020-09-0121
OAAI
Anti-EGFR-resistant clones decay exponentially after progression: implications for anti-EGFR re-challenge

抗EGFR耐药克隆在进展后呈指数衰减: 抗EGFR再攻击的意义

2019-02-01152
OAAI
Dual Inhibition of EGFR and c-Src by Cetuximab and Dasatinib Combined with FOLFOX Chemotherapy in Patients with Metastatic Colorectal Cancer
2017-08-0146
OAAI